News

Please click here to see the latest news stories relating to Covid-19
 
 

Bionow members are welcome to submit PR items to this newsroom for all to see. Describing current activity and progress in the sector, it's a great place to promote your orgnaisation and keep up to date with the latest developments.

Whether currently a member or not, also keep up to date with all the latest news and events by registering to receive the Bionow newsletter.

Sygnature has significantly expanded our DMPK capabilities and expertise with the acquisition of XenoGesis, the UK’s largest independent laboratory-based CRO specialising in pre-clinical D...

Quay Pharma (Deeside, UK) and Liverpool John Moores University (LJMU – Liverpool, UK) are delighted to announce that their Knowledge Transfer Partnership (KTP) funding application has been...

Dr Dave Tudor, previously Head of Manufacturing Strategy for GSK, has been appointed Managing Director of the Medicines Manufacturing Innovation Centre, a unique facility offering transforma...

Health experts, academics and business leaders tackling the global threat of drug-resistant bacteria are gathering for the BioInfect Conference on November 8.

Efficiency of drug discovery will be radically increased by managing, analyzing and reporting all processes within and between projects.

Researchers from the University of Hull have presented some of the latest research in fighting germs and combatting disease at the British Science Festival.

Early detection and diagnosis can greatly increase the chances of survival when it comes to cancer, but some forms of the disease are more difficult to identify during the early stages

CLYZ Labs, an award-winning early-stage cancer diagnostics company, today announced that the first clinical trial involving its innovative Cancertain™ test has secured all regulatory appro...

Nexus Labs, a pioneering medical education startup, today announced the completion of a Seed funding round to launch its first product, SurgicalTeaching.com a digital platform aimed at enhan...

Lancaster University is pleased to announce that Dr Sherry Kothari will be the new Director of its Health Innovation Campus.

Maxwellia, a pioneering ‘prescription to over the counter’ medicines company, today announced that it has raised £700,000 in early-stage investment from the GM&C Life Sciences Fund, man...

Renephra, a medical device company, today announced that it has raised £231,000 from Deepbridge Capital and the GM&C Life Sciences Fund, managed by Catapult Ventures.

Our Valued Sponsors & Partners